| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/24/2004 | WO2004053452A2 Assays relating to toll-like receptor activity |
| 06/24/2004 | WO2004053169A1 Modulation of interleukin 18 expression |
| 06/24/2004 | WO2004053168A1 Modulation of adipophilin expression |
| 06/24/2004 | WO2004053167A1 Modulation of cd1d expression |
| 06/24/2004 | WO2004053163A1 Method for identifying, analyzing and/or cloning nucleic acid isoforms |
| 06/24/2004 | WO2004053162A1 Method of distinguishing drug-resistance of hepatitis b virus |
| 06/24/2004 | WO2004053160A2 Method to analyze polymeric nucleic acid sequence variations |
| 06/24/2004 | WO2004053154A1 Magnetism based nucleic acid amplification |
| 06/24/2004 | WO2004053138A1 Dec-205 (ly 75) / dcl-1 intergenic splice variants associated with hodkin’s disease, and uses thereof |
| 06/24/2004 | WO2004053137A2 Method for protein production |
| 06/24/2004 | WO2004053136A1 RICE CONFERRING RESISTANCE TO ENVIRONMENTAL STRESS BY TARGETING MnSOD TO THE CHLOROPLAST |
| 06/24/2004 | WO2004053135A2 Expression cassette encoding a hydroxyphenylpyruvate dioxygenase and herbicide-tolerant plants containing such a gene |
| 06/24/2004 | WO2004053134A1 Expression cassette encoding a 5-enolpyruvylshikimate-3-phosphate synthase (epsps) and herbicide-tolerant plants containing it |
| 06/24/2004 | WO2004053133A1 Fertile transplastomic leguminous plants |
| 06/24/2004 | WO2004053132A1 A salt tolerant l-myo-inositol 1 phosphate synthase and the process of obtaining the same |
| 06/24/2004 | WO2004053130A1 Regulatory zinc finger proteins |
| 06/24/2004 | WO2004053129A1 Methods and means for modulating cellulose biosynthesis in fiber producing plants |
| 06/24/2004 | WO2004053128A1 Mutations in gaba-b receptor 1 associated with epilepsy |
| 06/24/2004 | WO2004053127A1 Method of constructing assigned molecule and library comprising the same and method of using the same |
| 06/24/2004 | WO2004053126A1 Cold-induced expression vector |
| 06/24/2004 | WO2004053121A1 PROTEIN FORMING COMPLEX WITH c-Fos PROTEIN, NUCLEIC ACID ENCODING THE SAME AND METHOD OF USING THE SAME |
| 06/24/2004 | WO2004053119A1 Fluorescent proteins from aquatic species |
| 06/24/2004 | WO2004053118A1 Yeast treatment |
| 06/24/2004 | WO2004053117A2 Serine protease |
| 06/24/2004 | WO2004053111A1 Method of selecting escherichia coli strain overexpressing foreign gene, escherichia coli mutant thus selected and process for producing enzyme and compound using the same |
| 06/24/2004 | WO2004053106A2 Profiled regulatory sites useful for gene control |
| 06/24/2004 | WO2004053104A2 5’ cpg nucleic acids and methods of use |
| 06/24/2004 | WO2004053103A2 METHOD OF INTRODUCING siRNA INTO ADIPOCYTES |
| 06/24/2004 | WO2004053092A2 Human pellino polypeptides |
| 06/24/2004 | WO2004053090A2 Method and system for utilizing somatic cell nuclear transfer embryos as cell donors for additional nuclear transfer |
| 06/24/2004 | WO2004053088A2 Genetic computing using combinatorial transcription control |
| 06/24/2004 | WO2004053083A2 Modulation of fetoprotein transcription factor expression |
| 06/24/2004 | WO2004053082A2 Organogenic transformation and regeneration |
| 06/24/2004 | WO2004053079A2 Compositions, splice variants and methods relating to ovarian specific genes and proteins |
| 06/24/2004 | WO2004053078A2 METHODS FOR MODULATING IKKα ACTIVITY |
| 06/24/2004 | WO2004053075A2 Compositions, splice variants and methods relating to breast specific genes and proteins |
| 06/24/2004 | WO2004053073A2 HIGH EFFICACY ANTISENSE Riα PKA POLY-DNP OLIGORIBONUCLEOTIDES |
| 06/24/2004 | WO2004053070A2 Genetic modification of carotenoid content in plants |
| 06/24/2004 | WO2004053065A2 Disorazole polyketide synthase encoding polynucleotides |
| 06/24/2004 | WO2004053062A2 Bentgrass event asr-368 and compositions and methods for detection thereof |
| 06/24/2004 | WO2004053060A2 ANTISENSE MODULATION OF mitoNEET EXPRESSION |
| 06/24/2004 | WO2004053055A2 Transgenic maize with enhanced phenotype |
| 06/24/2004 | WO2004053054A2 Nk cell receptor conjugates for treating malignancies |
| 06/24/2004 | WO2004053053A2 Optimised protein synthesis |
| 06/24/2004 | WO2004052934A1 Monitor protein for measuring processing of protein |
| 06/24/2004 | WO2004052933A2 Peptide oligomers for use as hiv vaccines |
| 06/24/2004 | WO2004052932A2 Antibody (“11c7”) anti nogo a and its pharmaceutical use |
| 06/24/2004 | WO2004052929A2 Recombinant cell line |
| 06/24/2004 | WO2004052928A2 Midkine-like protein |
| 06/24/2004 | WO2004052927A1 A baldness related gene and the polypeptide encoded thereby, and uses thereof |
| 06/24/2004 | WO2004052925A2 Actinobacillus pleuropneumoniae virulence genes |
| 06/24/2004 | WO2004052909A2 Lna-cpg conjugates |
| 06/24/2004 | WO2004052311A2 Modulation of acteyl-coa acetyltransferase 2 expression |
| 06/24/2004 | WO2004052309A2 Modulation of stat 6 expression |
| 06/24/2004 | WO2004052306A2 Modulation of ppar-alpha expression |
| 06/24/2004 | WO2004052300A2 Modulation of alpha-methylacyl-coa racemase expression |
| 06/24/2004 | WO2004052297A2 TREATMENT OF HSV-RELATED PATHOLOGIES USING ssDNA |
| 06/24/2004 | WO2004052276A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 06/24/2004 | WO2004052097A2 Bacterial bioherbicide for control of grassy weeds |
| 06/24/2004 | WO2004052093A1 METHOD OF CONSTRUCTING NONHUMAN MAMMAL HAVING RNAi PHENOTYPE |
| 06/24/2004 | WO2004052092A1 Sigma receptor-deficient, mutant, non-human mammals and applications thereof |
| 06/24/2004 | WO2004052085A1 Transgenic pineapple plants with modified carotenoid levels and methods of their production |
| 06/24/2004 | WO2004041862A3 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 06/24/2004 | WO2004041183A3 Methods of treating pulmonary fibrotic disorders |
| 06/24/2004 | WO2004039839A3 Modified voltage-gated calcium channels |
| 06/24/2004 | WO2004024925A3 Collectin-complement activating protein chimeras |
| 06/24/2004 | WO2004024883A3 PAKs AS MODIFIERS OF THE CHK PATHWAY AND METHODS OF USE |
| 06/24/2004 | WO2004022716A3 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 06/24/2004 | WO2004022594A3 Immune modulatory compounds and methods |
| 06/24/2004 | WO2004022575A3 Bioinformatics analysis of cellular effects of artificial transcription factors |
| 06/24/2004 | WO2004021986A3 Improved compositions and methods for cdna synthesis |
| 06/24/2004 | WO2004016227A3 Screening methods for cognitive enhancers |
| 06/24/2004 | WO2004015085A3 Method and compositions relating to 5’-chimeric ribonucleic acids |
| 06/24/2004 | WO2004013278A3 Expression vectors |
| 06/24/2004 | WO2004012046A3 Method for analyzing readings of nucleic acid assays |
| 06/24/2004 | WO2004011650A3 Antigens encoded by alternative reading frame from pathogenic viruses |
| 06/24/2004 | WO2004011606A9 Macromolecular protection assay |
| 06/24/2004 | WO2004009794A3 NOVEL siRNA LIBRARIES AND THEIR PRODUCTION AND USE |
| 06/24/2004 | WO2004007753A3 Transgenic non-human mammals expressing a reporter nucleic acid under the regulation of androgen response elements |
| 06/24/2004 | WO2004007748A3 Deprotection and purification of oligonucleotides and their derivatives |
| 06/24/2004 | WO2004005474A3 A robust, inducible cardiac preferred expression system for transgenesis |
| 06/24/2004 | WO2004003513A3 Compositions and methods for determining the replication capacity of a pathogenic virus |
| 06/24/2004 | WO2004000871A3 Thioesterase-related nucleic acid sequences and methods |
| 06/24/2004 | WO2003097795A3 Constitutively translocating cell line |
| 06/24/2004 | WO2003086311A3 Methods for treating tweak-related conditions |
| 06/24/2004 | WO2003076631A3 Genetic products differentially expressed in tumors and use thereof |
| 06/24/2004 | WO2003075856A3 Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phage beta protein, or hydroxyurea |
| 06/24/2004 | WO2003050238A9 Receptor-targeted adenoviral vectors |
| 06/24/2004 | WO2003049686A3 Stabilization of hypoxia inducible factor (hif) alpha |
| 06/24/2004 | WO2003047336A3 TRANSGENIC ANIMALS BEARING HUMAN Igμ LIGHT CHAIN GENES |
| 06/24/2004 | WO2003036257A3 Immobilizing biological molecules |
| 06/24/2004 | WO2003024386A8 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis |
| 06/24/2004 | WO2003022028A3 Methods, reagents, kits and apparatus for protein function analysis |
| 06/24/2004 | WO2003018044A8 New drug |
| 06/24/2004 | WO2003016473A3 Bovine leptin protein, antisense and antibody |
| 06/24/2004 | WO2003015613A3 Molecular characteristics of non-small cell lung cancer |
| 06/24/2004 | WO2003014309A3 Interleukin-1 receptors in the treatment of diseases |
| 06/24/2004 | WO2003008560A8 A novel g protein-coupled receptor, gave8 |
| 06/24/2004 | WO2002102979A3 Transformation of mono- and di- cotyledonous plants |
| 06/24/2004 | WO2002097390A8 A quantitative hybridization assay for the analysis of nucleic acid |